Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 Finance Stocks With Dismal Earnings Prospects To Avoid

Published 01/07/2019, 07:52 AM
Updated 07/09/2023, 06:31 AM

The Finance sector witnessed major volatility in 2018 with share prices rallying at the start of the year, followed by a substantial downtrend. Election promises fulfilled by Trump kept investors bullish at the beginning, until factors i.e. the U.S.-China trade war, uncertainty over Brexit, changing yield curve and expectations of global economic slowdown among others, began weighing on the investor sentiments.

Thus, the year that began on an optimistic note turned out to be one of the worst since the 2008 financial crisis. Over the past year, the S&P 500 and Zacks Finance sector declined 7.1% and 14.4%, respectively.

Finance companies benefit from rate hikes as higher rates lead to increase in net interest income and net interest margin. However, flattening and sometimes even inversion of the yield curve, as witnessed in the past few weeks, is bad news for the sector.

Also, as the Federal Reserve has decided to lower the number of rate hikes planned for 2019, companies will not be able to reap benefits to the full extent.

Moreover, fears of global economic slowdown, Brexit-related issues and trade war uncertainty kept customers wary and led to lower investment activities, slowdown in loan demand and decline in consumer spending in 2018. Corporate spending is likely to remain low as well until there is further clarity on trade talks with China.

Further, the artificial intelligence wave has engulfed the finance sector, leading to large investments being made by companies to withstand the growing competition. While this spending will brighten prospects of the companies, it is likely to weigh on financials in the near-term.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Elevated expenses, due to technology-related investments, are likely to partially offset the benefits of rising interest rates, and thus might impact the bottom line.

Due to these factors, companies might not have been able to generate significant returns in 2018, and are not expected to deliver solid earnings in the near term as well.

Finance Stocks to Steer Clear Of

So, we suggest avoiding some finance stocks that don’t look attractive, even in a rising rate environment.

While it’s not easy to select such stocks from the vast finance sector universe, we have taken the help of Zacks Stock Screener to make this task relatively simpler.

We have shortlisted finance stocks with a market capitalization of at least $2 billion and a VGM Score of C or D. Further, these stocks carry a Zacks Rank #4 (Sell) or 5 (Strong Sell). Finally, selected stocks that are expected to deliver negative earnings in 2019.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Eaton (NYSE:ETN) Vance Corporation (NYSE:EV) : With a market cap of $4.1 billion, this investment manager currently has a Zacks Rank #4 and VGM Score of D. The company’s earnings for fiscal 2020 are expected to decline 36.8% year over year.

ProAssurance Corporation (NYSE:PRA) : With a market cap of $2.2 billion, the insurance provider has a Zacks Rank #4 and VGM Score of D. Earnings for 2019 of the company are likely to decline 9.9% year over year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

South State Corporation (NASDAQ:SSB) : On a year-over-year basis, the company’s 2019 earnings are projected to decline 2.3%. With a market cap of $3.1 billion, this bank currently has a Zacks Rank #4 and VGM Score of C.

W.R. Berkley Corporation (NYSE:WRB) : With a market cap of $8.8 billion, this stock currently has a Zacks Rank #4 and VGM Score of D. The company’s earnings for 2019 are expected to decline 2.1% year over year.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



South State Corporation (SSB): Free Stock Analysis Report

Eaton Vance Corporation (EV): Free Stock Analysis Report

ProAssurance Corporation (PRA): Free Stock Analysis Report

W.R. Berkley Corporation (WRB): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.